Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

O.N. Diagnostics hit with FDA warning letter

7 October 2026 · By · Wire by Fusion42

Published

7 October 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at auntminnie.com →

◆ Verified

Fusion42 · 11 October 2026 · Fusion42 review

The FDA issued a warning letter to O.N. Diagnostics over an uncleared software update to its VirtuOst VFA vertebral fracture assessment tool, requiring the company to halt commercial distribution of version 3.0.0 until compliance issues are resolved.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You face tighter FDA scrutiny on AI updates in medical imaging software. Stop sales of non-compliant versions now and revise validation to protect your market access.

◆ Coverage

1 source · 7 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfdamedical-softwareregulatory-compliancevertebral-fracture-assessmentmachine-learning